Penumbra projects fourth-quarter revenue growth of 21.4% to 22.0%, with full-year 2025 revenue expected to reach approximately $1.4 billion
TMS offers new hope to patients suffering from stroke, migraine, neuropathic pain, depression, and other disorders
AFib is a progressive condition where timely intervention is critical to disease management and, ultimately, the patient's quality of life
Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
The pharma company will donate more than seven tons of its active pharmaceutical ingredient (API) to bolster the American supply chain
Paxton alleges the companies marketed Plavix as a reliable defense against heart attacks, strokes, and blood clots while failing to disclose evidence that the drug could be ineffective or virtually useless for many people
Conjugated Estrogens Tablets are indicated for moderate to severe menopausal symptoms, including hot flashes, and for the prevention of postmenopausal osteoporosis in women at significant risk
Subscribe To Our Newsletter & Stay Updated
